Safety and feasibility of allogeneic cord blood-derived cell therapy in preterm infants with severe brain injury (ALLO trial): a phase-1 trial protocol

Safety and feasibility of allogeneic cord blood-derived cell therapy in preterm infants with severe brain injury (ALLO trial): a phase-1 trial protocol

Introduction Severe intraventricular haemorrhage (IVH) and white matter injury (WMI) are major neurological complications in preterm infants, leading to long-term neurodevelopmental impairments. Despite advances in neonatal care, effective treatments are lacking. Umbilical cord blood cell (UCBC) the...

Full description

Saved in:
Bibliographic Details
Main Authors: Atul Malhotra, Lin Liu, Abdul Razak, Rod W Hunt, Suzanne L Miller, Graham Jenkin, Michelle Martin, Kristyn Connelly, Courtney A McDonald, Lindsay Zhou, Madison CB Paton, Cathie Hart, Ngaire J Elwood
Format: Article
Language:English
Published: BMJ Publishing Group 2025-06-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/15/6/e100389.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://bmjopen.bmj.com/content/15/6/e100389.full

Similar Items